表紙
市場調查報告書

全球荷爾蒙避孕藥市場規模,佔有率,趨勢分析:各手法(藥丸,子宮內設備,貼片,植入,避孕環,注射),各地區,供應商環境,市場區隔預測(2018∼2025年)

Hormonal Contraceptive Market Size, Share & Trends Analysis Report By Method (Pill, Intrauterine Device (IUD), Patch, Implant, Vaginal Ring, Injectable), By Region, And Segment Forecasts, 2019 - 2026

出版商 Grand View Research, Inc. 商品編碼 640054
出版日期 內容資訊 英文 100 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球荷爾蒙避孕藥市場規模,佔有率,趨勢分析:各手法(藥丸,子宮內設備,貼片,植入,避孕環,注射),各地區,供應商環境,市場區隔預測(2018∼2025年) Hormonal Contraceptive Market Size, Share & Trends Analysis Report By Method (Pill, Intrauterine Device (IUD), Patch, Implant, Vaginal Ring, Injectable), By Region, And Segment Forecasts, 2019 - 2026
出版日期: 2019年06月25日內容資訊: 英文 100 Pages
簡介

本報告提供全球荷爾蒙避孕藥市場相關調查,市場現狀與成長預測,各手法,各地區趨勢,及加入此市場的主要企業的簡介等彙整資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 市場趨勢
    • 推動市場的要素
    • 阻礙市場的要素
  • 被優先的主要的機會
  • 產業分析
  • PESTEL分析
  • 競爭模式

第4章 各手法預測

  • 市場佔有率
  • 藥丸
  • 子宮內設備
  • 注射
  • 避孕環
  • 植入
  • 貼片

第5章 各地區預測

  • 市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第6章 競爭環境

  • 策略架構
  • 企業簡介
    • Allergan
    • Bayer AG
    • Merck & Co., Inc.
    • Pfizer
    • Afaxys, Inc.
    • Teva Pharmaceutical Industries Ltd
    • Agile Therapeutics
    • Apothecus Pharmaceutical Corp.

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-2-68038-348-5

The global hormonal contraceptive market size is expected to reach USD 27.5 billion by 2026, based on a new report by Grand View Research, Inc. It is projected to register a CAGR of 4.1% during the forecast period. Introduction of innovative products and growing awareness about reproductive and sexual health in emerging regions are likely to drive the growth.

Pill, Intrauterine Devices (IUD), injectable, vaginal rings, implants, and patches are various methods used for hormonal contraception. Hormonal contraception methods act on the endocrine system to prevent ovulation. Increasing number of women in developing economies are using contraceptives due to the rise in government initiatives and programs. This factor is anticipated to accelerate the market growth. For instance, according to the UN, approximately 64.0% of women between 15 and 49 years of age were using some form of family planning in 2015, be it traditional or modern. This figure stood at 36.0% in 1970.

The number of unintended pregnancies is the highest in U.S., which is about 3 million annually. Hence, the Center for Medicaid and CHIP Services (CMCS) established a Maternal and Infant Health Initiative for the Medicaid and Children's Health Insurance Program (CHIP) to promote use of effective methods of contraception and help women avoid such pregnancies.

IUD segment is expected to witness the fastest growth during the forecast period, attributed to the entry of new devices, availability of long-acting reversible birth control methods, and more than 99.0% effectivity. For instance, in September 2016, Allergan and Medicines360 launched new LILETTA, a levonorgestrel-releasing intrauterine system in U.S. The device is a single handed inserter and for use by women to prevent pregnancy for up to three years.

Further key findings from the study suggest:

  • High demand for contraceptive methods can be attributed to rising awareness about pills and devices, significance of family planning, and presence of supportive government policies improving access to these products
  • In 2018, pills accounted for the largest market share as these product are convenient to use and exhibit more than 99.0% effectivity when accurately consumed. Furthermore, ease of availability, fewer adverse effects, and presence of a large number of players can be contribute to this growth
  • North America held the largest market share in 2018 and is anticipated to maintain its dominance during the forecast period due to the presence of major market players, high per capita income, and supportive government initiatives
  • Asia Pacific is estimated to witness the fastest growth in the forthcoming years due to high unmet need, expected increase in coverage in the next 15 years, and increasing number of women in their reproductive age

Some of the key players operating in the hormonal contraceptive market are: Teva Pharmaceuticals Industries Ltd.; Bayer AG; Merck & Co. Inc.; Pfizer; Afaxys, Inc.; Agile Therapeutics; Allergan; and Apothecus Pharmaceutical Corporation.

Table of Content

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Method
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity flow analysis (Model 1)
    • 1.6.2 Volume price analysis (model 2)
  • 1.7 List of Secondary Sources
  • 1.8 Objectives
    • 1.8.1 Objective - 1
    • 1.8.2 Objective - 2

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Method
    • 2.2.2 Region
  • 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Trends & Outlook
  • 3.2 Market Segmentation
  • 3.3 Penetration & Growth Prospect Mapping
    • 3.3.1 Penetration Analysis
    • 3.3.2 Market Driver analysis
      • 3.3.2.1 Rise in government and NGO initiatives to promote contraceptive methods
      • 3.3.2.2 High unmet needs
    • 3.3.3 Market Restraint Analysis
      • 3.3.3.1 Rapidly aging population and rising prevalence of infertility
      • 3.3.3.2 Adverse effects associated with use of contraceptive drugs and devices
  • 3.4 Hormonal ContraceptiveMarket: Business Environment Analysis Tools
    • 3.4.1 Hormonal Contraceptive Market: PESTle Analysis
    • 3.4.2 Hormonal Contraceptive Market: Porter's Five Forces Analysis
  • 3.5 Regulatory & Reimbursement Scenario

Chapter 4 Hormonal Contraceptive Market: Method Analysis

  • 4.1 Hormonal Contraceptive Method Market Share Analysis, 2018 & 2026
  • 4.2 Hormonal Contraceptive Method Market: Segment Dashboard:
  • 4.3 Market Size & Forecasts and Trend Analysis, 2015 to 2026 for the Method Segment
    • 4.3.1 Pills
      • 4.3.1.1 Pills market, 2015 - 2026 (USD Million)
    • 4.3.2 Intrauterine Devices (IUD)
      • 4.3.2.1 IUD market, 2015 - 2026 (USD Million)
    • 4.3.3 Injectale
      • 4.3.3.1 Injectable market, 2015 - 2026 (USD Million)
    • 4.3.4 Vaginal Ring
      • 4.3.4.1 Vaginal ring market, 2015 - 2026 (USD Million)
    • 4.3.5 Implant
      • 4.3.5.1 Implant market, 2015 - 2026 (USD Million)
    • 4.3.6 Patch
      • 4.3.6.1. Patch market, 2015 - 2026 (USD Million)

Chapter 5 Hormonal ContraceptiveMarket: Regional Analysis

  • 5.1 Hormonal Contraceptive Regional Market Share Analysis, 2018 & 2026
  • 5.2 Hormonal Contraceptive Regional Market: Segment Dashboard
  • 5.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 5.4 Market Size, & Forecasts, and Trend Analysis, 2015 to 2026
    • 5.4.1 North America
      • 5.4.1.1 North America hormonal contraceptive market, 2015 - 2026 (USD Million)
      • 5.4.1.1.1 U.S.
      • 5.4.1.1.1.1 U.S. hormonal contraceptive market, 2015 - 2026 (USD Million)
      • 5.4.1.1.2 Canada
      • 5.4.1.1.2.1 Canada hormonal contraceptive market, 2015 - 2026 (USD Million)
    • 5.4.2 Europe
      • 5.4.2.1 Europe hormonal contraceptive market, 2015 - 2026 (USD Million)
      • 5.4.2.1.1 UK
      • 5.4.2.1.1.1 UK hormonal contraceptive market, 2015 - 2026 (USD Million)
      • 5.4.2.1.2 Germany
      • 5.4.2.1.2.1 Germany hormonal contraceptive market, 2015 - 2026 (USD Million)
    • 5.4.3 Asia Pacific
      • 5.4.3.1 Asia Pacific hormonal contraceptive market, 2015 - 2026 (USD Million)
      • 5.4.3.1.1 Japan
      • 5.4.3.1.1.1 Japan hormonal contraceptive market, 2015 - 2026 (USD Million)
      • 5.4.3.1.2 China
      • 5.4.3.1.2.1 China hormonal contraceptive market, 2015 - 2026 (USD Million)
    • 5.4.4 Latin America
      • 5.4.4.1 Latin America hormonal contraceptive market, 2015 - 2026 (USD Million)
      • 5.4.4.1.1 Brazil
      • 5.4.4.1.1.1 Brazil hormonal contraceptive market, 2015 - 2026 (USD Million)
      • 5.4.4.1.2 Mexico
      • 5.4.4.1.2.1 Mexico hormonal contraceptive market, 2015 - 2026 (USD Million)
    • 5.4.5 Middle East and Africa (MEA)
      • 5.4.5.1 MEA hormonal contraceptive market, 2015 - 2026 (USD Million)
      • 5.4.5.1.1 South Africa
      • 5.4.5.1.1.1 South Africa hormonal contraceptive market, 2015 - 2026 (USD Million)

Chapter 6 Competitive Analysis

  • 6.1 Strategic Framework/Competition Categorization
  • 6.3 Marketing Channels
    • 6.3.1 Direct marketing
    • 6.3.2 Indirect marketing
  • 6.4 Strategy Mapping
  • 6.5 Hormonal Contraceptive Competitive Landscape: Market Position Analysis (Based on products, Market Presence, and Recent Updates/Strategic Initiatives)
  • 6.6 Company Profiles
    • 6.6.1 Allergan
      • 6.6.1.1 Company overview
      • 6.6.1.2 Financial performace
      • 6.6.1.3 service benchmarking
      • 6.6.1.4 Strategic initiatives
      • 6.6.1.5 SWOT analysis
    • 6.6.2 Bayer AG
      • 6.6.2.1 Company overview
      • 6.6.2.2 Financial performace
      • 6.6.2.3 Service benchmarking
      • 6.6.2.4 Strategic initiatives
      • 6.6.2.5 SWOT analysis
    • 6.6.3 Merck & Co., Inc.
      • 6.6.3.1 Company overview
      • 6.6.3.2 Financial performace
      • 6.6.3.3 Service benchmarking
      • 6.6.3.4 Strategic initiatives
      • 6.6.3.5 SWOT analysis
    • 6.6.4 Pfizer
      • 6.6.4.1 Company overview
      • 6.6.4.2 Financial performace
      • 6.6.4.3 Service benchmarking
      • 6.6.4.4 Strategic initiatives
      • 6.6.4.5 SWOT analysis
    • 6.6.5 Afaxys, Inc.
      • 6.6.5.1 Company overview
      • 6.6.5.2 Financial performace
      • 6.6.5.3 Service benchmarking
      • 6.6.5.4 Strategic initiatives
      • 6.6.5.5 SWOT analysis
    • 6.6.6 Teva Pharmaceutical Industries Ltd
      • 6.6.6.1 Company overview
      • 6.6.6.2 Financial performace
      • 6.6.6.3 Service benchmarking
      • 6.6.6.4 Strategic initiatives
      • 6.6.6.5 SWOT analysis
    • 6.6.7 Agile Therapeutics
      • 6.6.7.1 Company overview
      • 6.6.7.2 Financial performace
      • 6.6.7.3 Service benchmarking
      • 6.6.7.4 Strategic initiatives
      • 6.6.7.5 SWOT analysis
    • 6.6.8 Apothecus Pharmaceutical Corp.
      • 6.6.8.1 Company overview
      • 6.6.8.2 Financial performace
      • 6.6.8.3 Service benchmarking
      • 6.6.8.4 Strategic initiatives
      • 6.6.8.5 SWOT analysis

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of secondary sources
  • TABLE 3 North America hormonal contraceptive market, by country, 2015 - 2026 (USD Million)
  • TABLE 4 North America hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
  • TABLE 5 U.S. hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
  • TABLE 6 Canada hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
  • TABLE 7 Europe hormonal contraceptive market, by country, 2015 - 2026 (USD Million)
  • TABLE 8 Europe hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
  • TABLE 9 UK hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
  • TABLE 10 Germany hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
  • TABLE 11 Asia Pacific hormonal contraceptive market, by country, 2015 - 2026 (USD Million)
  • TABLE 12 Asia Pacific hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
  • TABLE 13 Japan hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
  • TABLE 14 China hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
  • TABLE 15 Latin America hormonal contraceptive market, by country, 2015 - 2026 (USD Million)
  • TABLE 16 Latin America hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
  • TABLE 17 Brazil hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
  • TABLE 18 Mexico hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
  • TABLE 19 Middle East and Africa hormonal contraceptive market, by country, 2015 - 2026 (USD Million)
  • TABLE 20 Middle East and Africa hormonal contraceptive market, by method, 2015 - 2026 (USD Million)
  • TABLE 21 South Africa hormonal contraceptive market, by method, 2015 - 2026 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Hormonal contraceptive market outlook, 2018
  • Fig. 9 Hormonal contraceptive market trends & outlook
  • Fig. 10 Hormonal contraceptive market segmentation
  • Fig. 11 Penetration & growth prospect mapping
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 Hormonal contraceptive market - PESTLE analysis
  • Fig. 15 Hormonal contraceptive market: Porter's five forces model
  • Fig. 16 Hormonal contraceptive method market share analysis, 2018 & 2026
  • Fig. 17 Hormonal contraceptive market: Segment dashboard
  • Fig. 18 Pill market, 2015 - 2026 (USD Million)
  • Fig. 19 Intrauterine device market, 2015 - 2026 (USD Million)
  • Fig. 20 Injectable market, 2015 - 2026 (USD Million)
  • Fig. 21 Vaginal ring market, 2015 - 2026 (USD Million)
  • Fig. 22 Implant market, 2015 - 2026 (USD Million)
  • Fig. 23 Patch market, 2015 - 2026 (USD Million)
  • Fig. 24 Hormonal contraceptive regional market share analysis, 2018 & 2026
  • Fig. 25 Hormonal contraceptive regional market: Segment dashboard
  • Fig. 26 Regional market place: Key takeaways
  • Fig. 27 North America hormonal contraceptive market, 2015 - 2026 (USD Million)
  • Fig. 28 U.S. hormonal contraceptive market, 2015 - 2026 (USD Million)
  • Fig. 29 Canada hormonal contraceptive market, 2015 - 2026 (USD Million)
  • Fig. 30 Europe hormonal contraceptive market, 2015 - 2026 (USD Million)
  • Fig. 31 UK hormonal contraceptive market, 2015 - 2026 (USD Million)
  • Fig. 32 Germany hormonal contraceptive market, 2015 - 2026 (USD Million)
  • Fig. 33 Asia Pacific hormonal contraceptive market, 2015 - 2026 (USD Million)
  • Fig. 34 Japan hormonal contraceptive market, 2015 - 2026 (USD Million)
  • Fig. 35 China hormonal contraceptive market, 2015 - 2026 (USD Million)
  • Fig. 36 Latin America hormonal contraceptive market, 2015 - 2026 (USD Million)
  • Fig. 37 Brazil hormonal contraceptive market, 2015 - 2026 (USD Million)
  • Fig. 38 Mexico hormonal contraceptive market, 2015 - 2026 (USD Million)
  • Fig. 39 MEA hormonal contraceptive market, 2015 - 2026 (USD Million)
  • Fig. 40 South Africa hormonal contraceptive market, 2015 - 2026 (USD Million)
  • Fig. 41 Strategy framework
  • Fig. 42 Strategy mapping
  • Fig. 43 Hormonal contraceptive competitive landscape: Market position analysis (based on products, regional presence, and strategic initiatives)
Back to Top